BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Gufic BioSciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
509079
ISIN Demat
INE742B01025
Book Value (Rs)
66.2307167
NSE Symbol
GUFICBIO
Divident Yield %
0.02
Market Cap
(Rs In Cr.)
4,234
P/E (TTM)
67.02
EPS (TTM)
6.3
Face Value
(Rs)
1
Back
Gufic BioSciences consolidated net profit declines 35.68% in the December 2025 quarter
14-Feb-26   Hrs IST

Net profit of Gufic BioSciences declined 35.68% to Rs 12.42 crore in the quarter ended December 2025 as against Rs 19.31 crore during the previous quarter ended December 2024. Sales rose 11.37% to Rs 231.41 crore in the quarter ended December 2025 as against Rs 207.79 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales231.41207.79 11
OPM %14.2516.33 -
PBDT25.4130.88 -18
PBT17.7226.26 -33
NP12.4219.31 -36

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)